AORT
Price
$30.94
Change
-$0.55 (-1.75%)
Updated
Jul 17, 02:27 PM (EDT)
Capitalization
873.56M
14 days until earnings call
SONVY
Price
$57.89
Change
+$0.67 (+1.17%)
Updated
Jul 16 closing price
Capitalization
16.61B
Interact to see
Advertisement

AORT vs SONVY

Header iconAORT vs SONVY Comparison
Open Charts AORT vs SONVYBanner chart's image
Artivion
Price$30.94
Change-$0.55 (-1.75%)
Volume$327
Capitalization873.56M
Sonova Holding AG
Price$57.89
Change+$0.67 (+1.17%)
Volume$247.54K
Capitalization16.61B
AORT vs SONVY Comparison Chart in %
Loading...
AORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SONVY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AORT vs. SONVY commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AORT is a Hold and SONVY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 17, 2025
Stock price -- (AORT: $31.49 vs. SONVY: $57.89)
Brand notoriety: AORT and SONVY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AORT: 79% vs. SONVY: 945%
Market capitalization -- AORT: $873.56M vs. SONVY: $16.61B
AORT [@Medical Specialties] is valued at $873.56M. SONVY’s [@Medical Specialties] market capitalization is $16.61B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AORT’s FA Score shows that 0 FA rating(s) are green whileSONVY’s FA Score has 1 green FA rating(s).

  • AORT’s FA Score: 0 green, 5 red.
  • SONVY’s FA Score: 1 green, 4 red.
According to our system of comparison, SONVY is a better buy in the long-term than AORT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AORT’s TA Score shows that 4 TA indicator(s) are bullish while SONVY’s TA Score has 4 bullish TA indicator(s).

  • AORT’s TA Score: 4 bullish, 5 bearish.
  • SONVY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both AORT and SONVY are a bad buy in the short-term.

Price Growth

AORT (@Medical Specialties) experienced а -2.05% price change this week, while SONVY (@Medical Specialties) price change was -0.72% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.37%. For the same industry, the average monthly price growth was +3.69%, and the average quarterly price growth was -1.04%.

Reported Earning Dates

AORT is expected to report earnings on Oct 30, 2025.

SONVY is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Medical Specialties (-1.37% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SONVY($16.6B) has a higher market cap than AORT($874M). AORT has higher P/E ratio than SONVY: AORT (434.78) vs SONVY (22.22). AORT YTD gains are higher at: 10.143 vs. SONVY (-9.441). SONVY has higher annual earnings (EBITDA): 979M vs. AORT (26.8M). SONVY has higher revenues than AORT: SONVY (3.74B) vs AORT (354M).
AORTSONVYAORT / SONVY
Capitalization874M16.6B5%
EBITDA26.8M979M3%
Gain YTD10.143-9.441-107%
P/E Ratio434.7822.221,957%
Revenue354M3.74B9%
Total Cash58.9MN/A-
Total Debt358MN/A-
FUNDAMENTALS RATINGS
AORT vs SONVY: Fundamental Ratings
AORT
SONVY
OUTLOOK RATING
1..100
1973
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
10
Undervalued
PROFIT vs RISK RATING
1..100
5664
SMR RATING
1..100
9252
PRICE GROWTH RATING
1..100
4462
P/E GROWTH RATING
1..100
7655
SEASONALITY SCORE
1..100
5039

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SONVY's Valuation (10) in the null industry is significantly better than the same rating for AORT (94) in the Medical Specialties industry. This means that SONVY’s stock grew significantly faster than AORT’s over the last 12 months.

AORT's Profit vs Risk Rating (56) in the Medical Specialties industry is in the same range as SONVY (64) in the null industry. This means that AORT’s stock grew similarly to SONVY’s over the last 12 months.

SONVY's SMR Rating (52) in the null industry is somewhat better than the same rating for AORT (92) in the Medical Specialties industry. This means that SONVY’s stock grew somewhat faster than AORT’s over the last 12 months.

AORT's Price Growth Rating (44) in the Medical Specialties industry is in the same range as SONVY (62) in the null industry. This means that AORT’s stock grew similarly to SONVY’s over the last 12 months.

SONVY's P/E Growth Rating (55) in the null industry is in the same range as AORT (76) in the Medical Specialties industry. This means that SONVY’s stock grew similarly to AORT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AORTSONVY
RSI
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 7 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
60%
Momentum
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
58%
MACD
ODDS (%)
Bearish Trend 2 days ago
66%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
54%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
52%
Advances
ODDS (%)
Bullish Trend 8 days ago
75%
Bullish Trend 8 days ago
65%
Declines
ODDS (%)
Bearish Trend 11 days ago
66%
Bearish Trend 3 days ago
57%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
57%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
62%
View a ticker or compare two or three
Interact to see
Advertisement
AORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SONVY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TIIEX15.37N/A
N/A
Nuveen International Eq R6
FMEFX41.91N/A
N/A
Nuveen Small/Mid Cap Growth Opp R6
CUURX52.33N/A
N/A
Columbia Small Cap Value I Inst2
MSEPX22.80N/A
N/A
Morgan Stanley Inst Emerging Mkts C
VLSRX17.80N/A
N/A
Virtus KAR Long/Short Equity R6

AORT and

Correlation & Price change

A.I.dvisor indicates that over the last year, AORT has been loosely correlated with SIBN. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AORT jumps, then SIBN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AORT
1D Price
Change %
AORT100%
+0.96%
SIBN - AORT
47%
Loosely correlated
+1.06%
BSX - AORT
46%
Loosely correlated
-0.28%
ITGR - AORT
46%
Loosely correlated
-0.26%
TCMD - AORT
43%
Loosely correlated
+1.35%
SONVY - AORT
42%
Loosely correlated
+1.17%
More

SONVY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SONVY has been loosely correlated with ALC. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SONVY jumps, then ALC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SONVY
1D Price
Change %
SONVY100%
+1.17%
ALC - SONVY
51%
Loosely correlated
+1.13%
SAUHY - SONVY
48%
Loosely correlated
-1.08%
AORT - SONVY
42%
Loosely correlated
+0.96%
SNN - SONVY
40%
Loosely correlated
+0.82%
OFIX - SONVY
39%
Loosely correlated
-0.56%
More